Ilyang Pharm (Korea) Price Prediction

007570 Stock   11,090  210.00  1.86%   
As of today the value of rsi of Ilyang Pharm's share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

18

 
Oversold
 
Overbought
The successful prediction of Ilyang Pharm's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Ilyang Pharm, which may create opportunities for some arbitrage if properly timed.
Using Ilyang Pharm hype-based prediction, you can estimate the value of Ilyang Pharm from the perspective of Ilyang Pharm response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Ilyang Pharm to buy its stock at a price that has no basis in reality. In that case, they are not buying Ilyang because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Ilyang Pharm after-hype prediction price

    
  KRW 11300.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Ilyang Pharm Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
10,03910,04012,430
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Ilyang Pharm. Your research has to be compared to or analyzed against Ilyang Pharm's peers to derive any actionable benefits. When done correctly, Ilyang Pharm's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Ilyang Pharm.

Ilyang Pharm After-Hype Price Prediction Density Analysis

As far as predicting the price of Ilyang Pharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Ilyang Pharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Ilyang Pharm, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Ilyang Pharm Estimiated After-Hype Price Volatility

In the context of predicting Ilyang Pharm's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Ilyang Pharm's historical news coverage. Ilyang Pharm's after-hype downside and upside margins for the prediction period are 11,299 and 11,301, respectively. We have considered Ilyang Pharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
11,090
11,299
Downside
11,300
After-hype Price
11,301
Upside
Ilyang Pharm is very steady at this time. Analysis and calculation of next after-hype price of Ilyang Pharm is based on 3 months time horizon.

Ilyang Pharm Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Ilyang Pharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ilyang Pharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Ilyang Pharm, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.32 
1.22
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
11,090
11,300
0.00 
0.00  
Notes

Ilyang Pharm Hype Timeline

Ilyang Pharm is presently traded for 11,090on Korea Stock Exchange of Korea. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Ilyang is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.32%. %. The volatility of related hype on Ilyang Pharm is about 0.0%, with the expected price after the next announcement by competition of 11,090. About 27.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.56. In the past many companies with similar price-to-book ratios have beat the market. Ilyang Pharm last dividend was issued on the 28th of December 2022. The entity had 2:1 split on the 28th of June 2006. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days.
Check out Ilyang Pharm Basic Forecasting Models to cross-verify your projections.

Ilyang Pharm Related Hype Analysis

Having access to credible news sources related to Ilyang Pharm's direct competition is more important than ever and may enhance your ability to predict Ilyang Pharm's future price movements. Getting to know how Ilyang Pharm's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Ilyang Pharm may potentially react to the hype associated with one of its peers.

Ilyang Pharm Additional Predictive Modules

Most predictive techniques to examine Ilyang price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ilyang using various technical indicators. When you analyze Ilyang charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Ilyang Pharm Predictive Indicators

The successful prediction of Ilyang Pharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ilyang Pharm, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ilyang Pharm based on analysis of Ilyang Pharm hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Ilyang Pharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Ilyang Pharm's related companies.

Story Coverage note for Ilyang Pharm

The number of cover stories for Ilyang Pharm depends on current market conditions and Ilyang Pharm's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Ilyang Pharm is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Ilyang Pharm's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Ilyang Pharm Short Properties

Ilyang Pharm's future price predictability will typically decrease when Ilyang Pharm's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Ilyang Pharm often depends not only on the future outlook of the potential Ilyang Pharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ilyang Pharm's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding18.2 M

Complementary Tools for Ilyang Stock analysis

When running Ilyang Pharm's price analysis, check to measure Ilyang Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilyang Pharm is operating at the current time. Most of Ilyang Pharm's value examination focuses on studying past and present price action to predict the probability of Ilyang Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilyang Pharm's price. Additionally, you may evaluate how the addition of Ilyang Pharm to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories